CJC 1295 with DAC lyophilized peptide for in vitro research.
Out of Stock
Bulk Discounts
| Quantity | Discount |
|---|---|
| 2+ | 5% off |
| 5+ | 10% off |
| 10+ | 15% off |
SKU: CJC-W-DAC-5MG
Category: peptide, Onyxresearch
CJC 1295 with DAC (Drug Affinity Complex) is an extended half-life GHRH analog. The DAC modification prolongs the peptide's bioavailability in vitro. This 5mg lyophilized preparation is intended for laboratory research only.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.
Onyx Research is a chemical supplier. Onyx Research is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Onyx Research is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
THE PRODUCTS WE OFFER ARE NOT INTENDED FOR HUMAN USE. THEY ARE INTENDED FOR IN-VITRO AND PRE-CLINICAL RESEARCH PURPOSES ONLY. THE CUSTOMER ACKNOWLEDGES THAT THERE ARE RISKS IN THE HANDLING, USE, AND DISTRIBUTION OF THESE PRODUCTS, AND CERTIFIES THAT IT HAS THE PROPER EQUIPMENT, FACILITIES, AND PERSONNEL FOR MANAGING THOSE RISKS; AND THE CUSTOMER KNOWINGLY ACCEPTS THESE RISKS.
© 2026 Onyx Research.
